Spots Global Cancer Trial Database for gastric mixed adenocarcinoma
Every month we try and update this database with for gastric mixed adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer | NCT01260701 | Adenocarcinoma ... Diffuse Gastric... Gastric Intesti... Gastric Mixed A... Recurrent Gastr... | Akt Inhibitor M... | 18 Years - | National Cancer Institute (NCI) | |
Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer | NCT01260701 | Adenocarcinoma ... Diffuse Gastric... Gastric Intesti... Gastric Mixed A... Recurrent Gastr... | Akt Inhibitor M... | 18 Years - | National Cancer Institute (NCI) |